KDL Biotech Ltd

KDL Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

KDL Biotech Ltd

₹ 2.14 -4.89%
16 Mar 2015
Company website BSE: 532291
About

KDL Biotech Limited manufactures biotechnology based products. The Group specializes in Semi-synthetic Penicillins and related Enzymes.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 2.14
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -24.6
  • Dividend Yield 0.00 %
  • ROCE -108 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
5.12 0.99 0.00 0.00 0.00 0.00 0.00 0.00
5.41 2.23 0.70 0.44 1.17 0.31 0.30 0.34
Operating Profit -0.29 -1.24 -0.70 -0.44 -1.17 -0.31 -0.30 -0.34
OPM % -5.66% -125.25%
0.12 0.07 0.06 0.10 0.13 0.04 0.04 0.02
Interest 1.72 1.71 1.73 1.73 1.69 1.22 1.23 1.27
Depreciation 1.72 1.72 1.74 1.74 1.70 1.72 1.74 1.74
Profit before tax -3.61 -4.60 -4.11 -3.81 -4.43 -3.21 -3.23 -3.33
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-3.61 -4.60 -4.11 -3.81 -4.43 -3.21 -3.23 -3.33
EPS in Rs -1.50 -1.91 -1.71 -1.59 -1.84 -1.34 -1.34 -1.39
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2006 6m Sep 2007 18m Sep 2008 Mar 2010 18m Mar 2011 Mar 2012 TTM
55 165 57 38 28 26 0
59 198 66 55 45 29 2
Operating Profit -3 -33 -9 -17 -16 -2 -2
OPM % -6% -20% -17% -44% -58% -8%
1 42 6 15 -11 1 0
Interest 5 13 10 3 7 7 5
Depreciation 4 10 7 12 22 9 7
Profit before tax -11 -13 -21 -17 -57 -17 -14
Tax % 0% 0% 0% 0% 14% 0%
-11 -14 -21 -17 -64 -17 -14
EPS in Rs -8.79 -7.08 -26.76 -7.16 -5.91
Dividend Payout % 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -22%
TTM: -100%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 6%
TTM: 12%
Stock Price CAGR
10 Years: 0%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2006 Sep 2007 Sep 2008 Mar 2010 Mar 2011 Mar 2012
Equity Capital 17 17 24 24 24 24
Reserves -9 -9 15 -2 -66 -83
106 85 64 57 60 60
33 62 16 26 47 56
Total Liabilities 147 154 119 106 65 57
83 75 77 75 57 48
CWIP 0 0 6 4 0 0
Investments 0 0 0 0 0 0
64 79 36 27 8 9
Total Assets 147 154 119 106 65 57

Cash Flows

Figures in Rs. Crores

Mar 2006 Sep 2007 Sep 2008 Mar 2010 Mar 2011 Mar 2012
-1 3 -6 3 2 7
-0 -2 -15 -1 -0 0
-1 -2 22 -3 -2 -7
Net Cash Flow -2 -1 1 -1 -0 0

Ratios

Figures in Rs. Crores

Mar 2006 Sep 2007 Sep 2008 Mar 2010 Mar 2011 Mar 2012
Debtor Days 210 50 7 1 4 0
Inventory Days 118 72 55 75 126 195
Days Payable 234 129 114 469 249 426
Cash Conversion Cycle 93 -7 -53 -393 -119 -230
Working Capital Days 146 21 75 -75 -497 -643
ROCE % -18% -11% -23% -78% -108%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports